Previous investigations with hormone-dependent prostate cancer cell lines (LNCaP) showed that BRE supplementation significantly decreased the expression of androgen-related genes, including androgen receptors (AR), prostate-specific antigens (PSA), and 5-alpha reductase 2. The gene discussed is KLK3; the disease is prostate cancer.